Top Markets
#1 Islamic Coin Islamic Coin +152.11%
#2 龙虾 (Lobster) 龙虾 (Lobster) +56.69%
#3 SODAX SODAX +52.42%
#4 Cortex Cortex +32.15%
#5 DexNet DexNet +23.20%
#6 OpenEden OpenEden +20.10%
#7 Akedo Akedo +19.38%
#8 Pons Pons +18.51%
#9 BNB Attestation Service BNB Attestation Service +14.51%
#10 APEX APEX +13.93%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Hualan Biological Bacterin Inc. Hualan Biological Bacterin Inc.

Hualan Biological Bacterin Inc.

301207
Rank in Stocks #7578
Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on... Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on the entire vaccine lifecycle, from research and development to manufacturing and sales within China. The company's product line features a diverse range of immunizations, including various influenza virus vaccines (such as split, quadrivalent, and H1N1 strains), recombinant hepatitis B vaccines, and meningococcal polysaccharide vaccines (including ACYW135 and Group A & C types). They also develop genetically engineered vaccines for human use. Established in 2005, Hualan Biological Bacterin Inc. is headquartered in Xinxiang, China, and previously operated as a subsidiary of Hualan Biological Engineering Inc.
Share Price
$2.58
Market Cap
$1.54B
Change (1 day)
-2.46%
Change (1 year)
2.58%
Country
CN
Trade Hualan Biological Bacterin Inc. (301207)

Category

Healthcare
Earnings for Hualan Biological Bacterin Inc. (301207)
Earnings in 2026 TTM: 0
According to Hualan Biological Bacterin Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Hualan Biological Bacterin Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH